Sage Journals: Discover world-class research

Open access

Research article

First published 2021-7

Vascular cell-specific roles of mineralocorticoid receptors in pulmonary hypertension

Divya P. Menon, Guanming Qi, Seung K. Kim [...]

Pulmonary Circulation

Free access

Review article

First published 2014-10

Current state of endothelin receptor antagonism in hypertension and pulmonary hypertension

Kazuya Miyagawa, Noriaki Emoto

Therapeutic Advances in Cardiovascular Disease

Free access

Review article

First published 2011-1

Is Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) a Therapeutic Target for the Treatment of Pulmonary Hypertension?

David E. Green, Roy L. Sutliff, C. Michael Hart

Pulmonary Circulation

Free access

Research article

First published 2015-12

Expression of Mutant Bone Morphogenetic Protein Receptor II Worsens Pulmonary Hypertension Secondary to Pulmonary Fibrosis

Andrew J. Bryant, Linda J. Robinson, Christy S. Moore [...]

Pulmonary Circulation

Open access

Case report

First published 2017-5

First-in-child use of the oral selective prostacyclin IP receptor agonist selexipag in pulmonary arterial hypertension

Lianne M. Geerdink, Harald Bertram, Georg Hansmann

Pulmonary Circulation

Free access

Review article

First published 2014-6

The potential for macitentan,a new dual endothelin receptor antagonist,in the treatment of pulmonary arterial hypertension

Alexandru Steriade, Andrei Seferian, Xavier Jaïs [...]

Therapeutic Advances in Respiratory Disease

Open access

Research article

First published 2021-1

Circulating nerve growth factor receptor positive cells are associated with severity and prognosis of pulmonary arterial hypertension

Chiaki Goten, Soichiro Usui, Shin-ichiro Takashima [...]

Pulmonary Circulation

Open access

Research article

First published 2020-10

Comparative effectiveness of endothelin receptor antagonists on mortality in patients with pulmonary arterial hypertension in a US Medicare population: a retrospective database analysis

Raymond L. Benza, Cassandra A. Lickert, Lin Xie [...]

Pulmonary Circulation

Open access

Research article

First published 2020-4

A non-selective endothelin receptor antagonist bosentan modulates kinetics of bone marrow-derived cells in ameliorating pulmonary hypertension in mice

Taichi Kato, Yoshihide Mitani, Masahiro Masuya [...]

Pulmonary Circulation

Open access

Review article

First published 2019

Treatment of pulmonary arterial hypertension with the dual endothelin receptor antagonist macitentan: clinical evidence and experience

Catharina Belge, Marion Delcroix

Therapeutic Advances in Respiratory Disease

Search results